Bank of America’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-30,000
Closed -$2.05M 7906
2023
Q2
$2.05M Buy
+30,000
New +$1.93M ﹤0.01% 4216
2021
Q2
Sell
-98,000
Closed -$2.46M 8005
2021
Q1
$2.46M Buy
+98,000
New +$1.84M ﹤0.01% 4076
2020
Q1
Sell
-18,600
Closed -$294K 7159
2019
Q4
$294K Buy
+18,600
New +$199K ﹤0.01% 5380
2018
Q3
Sell
-94,500
Closed -$1.38M 7427
2018
Q2
$1.38M Buy
+94,500
New +$1.87M ﹤0.01% 4260
2018
Q1
Sell
-1,400
Closed -$52K 7286
2017
Q4
$52K Buy
+1,400
New +$71.3K ﹤0.01% 6052

Other funds holding PRTA

Bank of America's PRTA Position: Q1 2026 in Review

Bank of America reduced its Prothena Corp (PRTA) stake by 7.9% in Q1 2026, selling an estimated $309K and leaving 393,632 shares worth $3.83M. The position accounts for ﹤0.01% of the portfolio, ranked #3660.

Bank of America first reported a position in PRTA in Q2 2013 and has held it in 52 quarters since. The position peaked at $37.3M in Q2 2014. 185 funds tracked by Wall St. Rank hold PRTA as of Q1 2026.

  • Bank of America held 393,632 shares of Prothena Corp worth $3.83M as of Q1 2026.
  • Bank of America sold 33,728 Prothena Corp shares in Q1 2026, an estimated $309K.
  • Prothena Corp made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3660 holding.
  • Bank of America first reported a position in Prothena Corp in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Prothena Corp position peaked at $37.3M in Q2 2014.
  • 185 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.